Bajaj Healthcare LtdPharmaceuticalsINE411U01027Standalone₹329.05+0.50 (+0.15%)Jun-26
Valuation
Market Cap₹1.11K Cr
TTM PE-128.04x
Forward PE-114.78x
PEG16.23
Book Value₹158.34
P/B2.08x
TTM EPS₹-2.57
Fwd EPS₹-2.87
TTM Revenue₹627.83 Cr
TTM PAT₹17.63 Cr
TTM EBITDA₹109.05 Cr
TTM EBIT₹80.13 Cr
Last Qtr PAT₹13.70 Cr
Last Qtr EBITDA₹28.75 Cr
Last Qtr EBIT₹21.74 Cr
Profitability
ROE3.31%
ROCE7.00%
TTM NPM2.81%
TTM EBITDA %17.37%
Curr OPM8.23%
Last OPM-14.65%
Curr NPM
Last NPM
Curr EPS₹4.07
Last EPS₹-6.08
Balance sheet
Equity₹16.83 Cr
Reserve₹516.17 Cr
Total Debt₹249.10 Cr
D/E0.47x
Interest %44.45%
Curr Interest₹6.09 Cr
Price / range
Close₹329.05
vs 52W High-36.26%
vs 52W Low+20.77%
MA50
MA200
Returns
1D+0.15%
1W-1.51%
1M+2.13%
3M+3.57%
6M+6.45%
1Y-22.91%
2Y-14.12%
3Y-22.75%
5Y-62.80%
Diwali-22.56%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr148.173.58%
DIVISLAB9375.00₹2.49L Cr84.6217.55%
TORNTPHARM4840.00₹1.84L Cr78.8025.43%
ZYDUSLIFE1160.00₹1.16L Cr33.2112.96%
CIPLA1394.50₹1.13L Cr36.648.93%
LAURUSLABS1954.00₹1.06L Cr120.9216.46%
AUROPHARMA1734.00₹99.77K Cr38.796.84%
DRREDDY1185.00₹98.91K Cr148.681.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue165.63+11.3%153.06161.22147.92148.84611.03
Other Income0.812.961.651.650.887.13
Total Income166.44+11.2%156.01162.87149.57149.71618.17
Interest6.095.575.885.565.2322.23
Expenditure-149.98-10.9%-143.58-143.63-133.61-135.19-556
PBDT000000
EBITDA28.75+17.3%22.6830.6726.9524.52104.81
Depreciation-7.01-7.63-7.20-7.08-5.64-27.55
EBIT21.74+15.1%15.0523.4719.8718.8877.26
PBT16.46+13.3%-20.8119.2515.9614.5328.92
Tax-2.571.40-3.14-3.51-2.35-7.61
Equity16.8316.830015.7916.83
OPM9.89-13.3411.9410.799.714.68
Net Profit13.70+15.8%-22.8515.6711.1111.8315.77
NPM8.23-14.659.727.517.902.55
EPS4.07+5.7%-6.08-0.14-0.423.856.73

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue611.03+12.6%542.60+14.6%473.42-29.7%673.29-1.0%679.89+3.5%656.98
Other Income7.1319.408.691.601.446.91
Total Income618.17+10.0%562.01+16.6%482.10-28.6%674.89-0.9%681.33+2.6%663.90
Expenditure-556-7.8%-516-13.5%-454.45+26.3%-616.67-4.2%-591.65-8.5%-545.08
Interest-22.23-27.90-29.68-22.87-12.62-8.30
PBDT000000
EBITDA104.81+27.2%82.42+8.1%76.27-28.6%106.85-9.8%118.50-13.1%136.32
Depreciation-27.55-27.92-27.62-27.36-17.64-16.12
EBIT77.26+41.8%54.50+12.0%48.65-38.8%79.49-21.2%100.86-16.1%120.20
PBT28.92-37.1%46.01+375.8%-16.68-128.6%58.22-35.1%89.69-24.5%118.82
Tax-7.61-3.082.35-15.19-18.30-35.71
Equity16.8315.790000
OPM (%)4.688.19-3.009.0013.0018.00
Net Profit15.77-60.1%39.50+147.1%-83.79-294.8%43.02-39.7%71.39-14.1%83.11
NPM (%)2.557.03-17.006.0010.0013.00
EPS (Rs)6.73-53.4%14.45+147.6%-30.36-294.7%15.59-39.7%25.87-57.0%60.23
CEPS6.7214.26-30.3615.5925.8760.23

Consolidated

16 lines · 1 periods
MetricFY25-26
Revenue611.03
Other Income7.13
Total Income618.17
Interest22.23
Expenditure-556
PBDT0
EBITDA104.81
Depreciation-27.55
EBIT77.26
PBT28.92
Tax-7.61
Equity16.83
OPM4.68
Net Profit15.77
NPM2.55
EPS6.73

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 2 years
MetricFY 25-26FY 24-25
Revenue611.03+12.6%542.60
Other Income7.1319.40
Total Income618.17+10.0%562.01
Expenditure-556-7.8%-516
Interest-22.23-27.90
PBDT00
EBITDA104.81+27.2%82.42
Depreciation-27.55-27.92
EBIT77.26+41.8%54.50
PBT28.92-37.1%46.01
Tax-7.61-3.08
Equity16.8315.79
OPM (%)4.688.19
Net Profit15.77-60.1%39.50
NPM (%)2.557.03
EPS (Rs)6.73-53.4%14.45
CEPS6.7214.26

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

9
YearTypeAmountEx-Date
2025Final Dividend119 Sep 2025
2024Final Dividend123 Sep 2024
2023Final Dividend122 Sep 2023
2022Final Dividend1.522 Sep 2022
2021Final Dividend0.528 Sep 2021
2021Special Dividend0.528 Sep 2021
2021Interim Dividend1.2501 Dec 2020
Special Dividend0.501 Dec 2020
2018Final Dividend119 Sep 2018

Bonus

1
YearRatioEx-Date
20191:109 Apr 2019

Split

1
YearRatioEx-Date
2021Rs.10/- to Rs.5/-28 Sep 2021
Loading company dashboard...
Fetching ratios, charts, and peers